Power Corporation of Canada
F:PCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Power Corporation of Canada
F:PCR
|
CA |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
US |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
R
|
Relx PLC
NYSE:RELX
|
UK |
|
K
|
Kinross Gold Corp
XETRA:KIN2
|
CA |
|
S
|
Solar Innovation SA
WSE:SIN
|
PL |
|
W
|
Western Digital Corp
DUS:WDC
|
US |
|
Informa PLC
LSE:INF
|
UK |
|
Wallenius Wilhelmsen ASA
OSE:WAWI
|
NO |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
|
Labrador Gold Corp
XTSX:LAB
|
CA |
|
C
|
CSL Ltd
OTC:CMXHF
|
AU |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
Samsung Electro-Mechanics Co Ltd
KRX:009150
|
KR |
|
D
|
Daiichi Life Group Inc
F:QHH
|
JP |
|
Weatherford International PLC
NASDAQ:WFRD
|
US |
|
Liberty Global Ltd
F:3O40
|
BM |
|
Republic Services Inc
NYSE:RSG
|
US |
|
IAMGOLD Corp
TSX:IMG
|
CA |
|
ASML Holding NV
LSE:0M42
|
NL |
|
Mercedes-Benz Group AG
SIX:MBG
|
DE |
|
C
|
Caterpillar Inc
BMV:CAT
|
US |
|
NTPC Ltd
NSE:NTPC
|
IN |
|
E
|
Eaton Corporation PLC
LSE:0Y3K
|
IE |
Discount Rate
PCR Cost of Equity
Discount Rate
PCR's Cost of Equity, calculated using the formula Risk-Free Rate + Beta x ERP, stands at 6.75%. The Beta, indicating the stock's volatility relative to the market, is 0.7, while the current Risk-Free Rate, based on government bond yields, is 3.74%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.3%.
What is PCR's discount rate?
PCR's current Cost of Equity is 6.75%.
In the valuation of banks and insurance companies, only the cost of equity is used due to their unique capital structures and regulatory environments.
These institutions heavily rely on debt, regulated more stringently than other industries, making the Weighted Average Cost of Capital (WACC) less applicable and accurate for them. The cost of equity offers a more direct measure of the risk and return expectations relevant to these specific sectors.
How is Cost of Equity for PCR calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
PCR